Skip to content
🌐 Global🇮🇳 India📍 Asia-Pacific📍 Bihar📍 Delhi-NCR📍 East India📍 Europe📍 Gujarat📍 Karnataka📍 Kerala📍 Madhya Pradesh📍 Maharashtra📍 Middle East📍 North India📍 Northeast India📍 Punjab📍 Rajasthan📍 South India📍 Tamil Nadu📍 Telangana📍 United Kingdom📍 United States📍 Uttar Pradesh📍 West Bengal📍 West India
LIVE
AMD rides data center riches to ‘largest and most profitable’ quarter in history◆Scepticism as Trump says he’s ending Israel’s $3.8 bn military aid deal◆All the news about The Legend of Zelda: Ocarina of Time remake◆Sources: Ex-QB Wilson interviews with NC State, joins Rivers as HC candidate◆'AK 47' film needs a big jump to match 'Ala Vaikunthapurramuloo'◆Jon Ossoff wins reelection in Georgia, easily defeating Republican Mike Collins◆Mumbai High Court Declares Corporators Uninvolved in Garbage Removal◆FBI Arrests Oklahoma Man Who Sent 700 Threatening Letters to U.S. Officials◆AMD rides data center riches to ‘largest and most profitable’ quarter in history◆Scepticism as Trump says he’s ending Israel’s $3.8 bn military aid deal◆All the news about The Legend of Zelda: Ocarina of Time remake◆Sources: Ex-QB Wilson interviews with NC State, joins Rivers as HC candidate◆'AK 47' film needs a big jump to match 'Ala Vaikunthapurramuloo'◆Jon Ossoff wins reelection in Georgia, easily defeating Republican Mike Collins◆Mumbai High Court Declares Corporators Uninvolved in Garbage Removal◆FBI Arrests Oklahoma Man Who Sent 700 Threatening Letters to U.S. Officials◆
Home / Science
Science

Semiautomated platform delivers consistent batches of extracellular vesicles for potential regenerative therapies

A study led by researchers from the Germans Trias i Pujol Research Institute (IGTP) and the Blood and Tissue Bank (BST) has developed and validated a manufacturing platform for extracellular vesicles that meets pharmaceutical quality requirements, marking a key step toward their clinical application

Phys.org ScienceNovember 4, 20261 min read
Share this story
Semiautomated platform delivers consistent batches of extracellular vesicles for potential regenerative therapies

A study led by researchers from the Germans Trias i Pujol Research Institute (IGTP) and the Blood and Tissue Bank (BST) has developed and validated a manufacturing platform for extracellular vesicles that meets pharmaceutical quality requirements, marking a key step toward their clinical application.

scienceworld
📡 Verified Wire Agency Verified Resource & Provenance
Original Resource
Phys.org Science
Read Wire Dispatch → Share on 𝕏
✉
The Next Brief
Get the day's most important stories in one email
AI-curated morning digest. No noise. Unsubscribe anytime.

Comments 0

Advertisement

Related stories

Science
North Atlantic's 'cold blob' may contain climate nuance
Phys.org Science · November 4, 2026
Science
US midterm elections: Younger politicians could strengthen trust in democracy
Phys.org Science · November 4, 2026
Science
Asymmetric atomic structure improves sodium, sulfur battery performance
Phys.org Science · November 3, 2026
Science
Finding the fingerprints of noisy distributions in random quantum systems
Phys.org Science · November 3, 2026

Most read

  1. 1Kerala's Calicut University: Probe into Answer Script Storage ScandalLifestyle
  2. 2Rimi Tomy hints at second marriageEntertainment
  3. 3Jordan's King Abdullah Vows to Confront Terrorists After Karak AttackWorld
  4. 4CCTV Footage Revives Probe into Adoor Police Station AttackPolitics
  5. 5Inside the Abdul El-Sayed-Haley Stevens Meltdown in Michigan - The New York TimesTop Stories